• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals

tetano

Editor, Senior Moderator
PLoS One


. 2021 Aug 25;16(8):e0244468.
doi: 10.1371/journal.pone.0244468. eCollection 2021.
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals


Harsha Doddapaneni[SUP] 1 [/SUP], Sara Javornik Cregeen[SUP] 2 3 [/SUP], Richard Sucgang[SUP] 2 [/SUP], Qingchang Meng[SUP] 1 [/SUP], Xiang Qin[SUP] 1 [/SUP], Vasanthi Avadhanula[SUP] 3 [/SUP], Hsu Chao[SUP] 1 [/SUP], Vipin Menon[SUP] 1 [/SUP], Erin Nicholson[SUP] 3 4 [/SUP], David Henke[SUP] 3 [/SUP], Felipe-Andres Piedra[SUP] 3 [/SUP], Anubama Rajan[SUP] 3 [/SUP], Zeineen Momin[SUP] 1 [/SUP], Kavya Kottapalli[SUP] 1 [/SUP], Kristi L Hoffman[SUP] 2 3 [/SUP], Fritz J Sedlazeck[SUP] 1 [/SUP], Ginger Metcalf[SUP] 1 [/SUP], Pedro A Piedra[SUP] 3 4 [/SUP], Donna M Muzny[SUP] 1 [/SUP], Joseph F Petrosino[SUP] 2 3 [/SUP], Richard A Gibbs[SUP] 1 [/SUP]



Affiliations
Free article

Abstract

The newly emerged and rapidly spreading SARS-CoV-2 causes coronavirus disease 2019 (COVID-19). To facilitate a deeper understanding of the viral biology we developed a capture sequencing methodology to generate SARS-CoV-2 genomic and transcriptome sequences from infected patients. We utilized an oligonucleotide probe-set representing the full-length genome to obtain both genomic and transcriptome (subgenomic open reading frames [ORFs]) sequences from 45 SARS-CoV-2 clinical samples with varying viral titers. For samples with higher viral loads (cycle threshold value under 33, based on the CDC qPCR assay) complete genomes were generated. Analysis of junction reads revealed regions of differential transcriptional activity among samples. Mixed allelic frequencies along the 20kb ORF1ab gene in one sample, suggested the presence of a defective viral RNA species subpopulation maintained in mixture with functional RNA in one sample. The associated workflow is straightforward, and hybridization-based capture offers an effective and scalable approach for sequencing SARS-CoV-2 from patient samples.
 
Back
Top Bottom